ALEMBIC PHARMS LTD
GenericsALEMBIC PHARMS LTD is a generic drug manufacturer focused on Cardiovascular, Neurology, Respiratory. Key products include DESVENLAFAXINE.
ALEMBIC PHARMS LTD's Key Drugs
ALEMBIC PHARMS LTD's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
ALEMBIC PHARMS LTD's Recent FDA Approvals
ALEMBIC PHARMS LTD secured 1 new FDA approval for novel drugs (NDA/BLA) in the last two years.
ALEMBIC PHARMS LTD's Therapeutic Areas
ALEMBIC PHARMS LTD's approved drugs and pipeline span 4 therapeutic areas, led by Cardiovascular and Neurology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
ALEMBIC PHARMS LTD's Top Competitors
ALEMBIC PHARMS LTD's closest competitors by therapeutic-area and drug-target overlap include GE HEALTHCARE, CHIESI, and ACTELION. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
ALEMBIC PHARMS LTD Pipeline Snapshot
Active clinical trials for ALEMBIC PHARMS LTD across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (1)
Company Info
- First Approval
- 2009-02-18
- Latest
- 2026-04-13
- Applications
- 32